256 related articles for article (PubMed ID: 21151878)
1. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
[TBL] [Abstract][Full Text] [Related]
4. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
5. Association of APOL1 renal disease risk alleles with Trypanosoma brucei rhodesiense infection outcomes in the northern part of Malawi.
Kamoto K; Noyes H; Nambala P; Senga E; Musaya J; Kumwenda B; Bucheton B; Macleod A; Cooper A; Clucas C; Herz-Fowler C; Matove E; Chiwaya AM; Chisi JE;
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007603. PubMed ID: 31412021
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome profiles of Trypanosoma brucei rhodesiense in Malawi reveal focus specific gene expression profiles associated with pathology.
Nambala P; Noyes H; Namulondo J; Nyangiri O; Alibu VP; Nerima B; MacLeod A; Matovu E; Musaya J; Mulindwa J;
PLoS Negl Trop Dis; 2024 May; 18(5):e0011516. PubMed ID: 38701067
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence.
Goodhead I; Capewell P; Bailey JW; Beament T; Chance M; Kay S; Forrester S; MacLeod A; Taylor M; Noyes H; Hall N
mBio; 2013 Aug; 4(4):. PubMed ID: 23963174
[TBL] [Abstract][Full Text] [Related]
8. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
MacLean L; Reiber H; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
10. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.
Fèvre EM; Odiit M; Coleman PG; Woolhouse ME; Welburn SC
BMC Public Health; 2008 Mar; 8():96. PubMed ID: 18366755
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Trypanosoma brucei rhodesiense genetic diversity and clinical spectrum among sleeping sickness patients in Uganda.
Kato CD; Mugasa CM; Nanteza A; Matovu E; Alibu VP
BMC Res Notes; 2017 Oct; 10(1):518. PubMed ID: 29078807
[TBL] [Abstract][Full Text] [Related]
12. Genetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and Nagana.
Echodu R; Sistrom M; Bateta R; Murilla G; Okedi L; Aksoy S; Enyioha C; Enyaru J; Opiyo E; Gibson W; Caccone A
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003353. PubMed ID: 25695634
[TBL] [Abstract][Full Text] [Related]
13. No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations.
Kimuda MP; Noyes H; Mulindwa J; Enyaru J; Alibu VP; Sidibe I; Mumba Ngoyi D; Hertz-Fowler C; MacLeod A; Tastan Bishop Ö; Matovu E;
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006300. PubMed ID: 29470556
[TBL] [Abstract][Full Text] [Related]
14. Plasma cytokines quantification among
Kamoto K; Chiwaya A; Nambala P; Chammudzi P; Senga E; Chisi J; Matovu E; Musaya J
Malawi Med J; 2021 Dec; 33(4):230-235. PubMed ID: 35291381
[TBL] [Abstract][Full Text] [Related]
15. Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile.
MacLean L; Chisi JE; Odiit M; Gibson WC; Ferris V; Picozzi K; Sternberg JM
Infect Immun; 2004 Dec; 72(12):7040-4. PubMed ID: 15557627
[TBL] [Abstract][Full Text] [Related]
16. Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.
Kipkorir LW; John TK; Owino OB; John O; Robert S; Daniel M; Owino AV
Exp Parasitol; 2021 Sep; 228():108135. PubMed ID: 34284027
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for T. brucei rhodesiense sleeping sickness within villages in south-east Uganda.
Zoller T; Fèvre EM; Welburn SC; Odiit M; Coleman PG
BMC Infect Dis; 2008 Jun; 8():88. PubMed ID: 18590541
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of trypanosomiasis in Rumphi district, Malawi: a ten year retrospective study.
Madanitsa M; Chisi J; Ngwira B
Malawi Med J; 2009 Mar; 21(1):22-7. PubMed ID: 19780474
[TBL] [Abstract][Full Text] [Related]
19. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.
Fèvre EM; Coleman PG; Odiit M; Magona JW; Welburn SC; Woolhouse ME
Lancet; 2001 Aug; 358(9282):625-8. PubMed ID: 11530149
[TBL] [Abstract][Full Text] [Related]
20. Differences in gene expression profiles in early and late stage rhodesiense HAT individuals in Malawi.
Nambala P; Mulindwa J; Noyes H; Alibu VP; Nerima B; Namulondo J; Nyangiri O; Matovu E; MacLeod A; Musaya J;
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011803. PubMed ID: 38055777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
